Medication Management

Big responses seen for right to not offer procedures due to religious beliefs and condemning deception ‘in patient’s best interest’

B.C. reveals changes to pricing and reimbursement of new generics and a frequent-dispensing policy.

Bristol-Myers Squibb's Reyataz is now indicated for the treatment of HIV-1 infection in children six to 18 years of age.

Alberta Health and Wellness Minister Ron Liepert announced details of the first phase of the province's major new pharmaceutical strategy on December 8.

Canada is the first country worldwide to approve Janssen-Ortho's Stelara for the treatment of psoriasis.

Many CML patients today are living with side effects so strong that their quality of life is greatly reduced, according to a survey by the CML Society of Canada.